Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription drug, in Europe for orphan and/or rare diseases SAN ...

BOCA RATON, FL / ACCESSWIRE / November 19, 2024 / WoundZoom is thrilled to introduce WoundZoom LIGHT, a HIPAA-compliant point ...

Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK, CA / ACCESSWIRE / November 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" ...

With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.SCOTTSDALE, AZ / ACCESSWIRE / ...

We all have a unique face, fingerprint, voice and signature, so why wouldn’t we have a unique response to the medicine and ...

Pharmacovigilance (PV) is an essential component of drug safety that involves the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. As ...

TORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a ...

DALLAS, TX / ACCESSWIRE / November 19, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the appointment of Dr. Hiroshi Ohrui to its Scientific Advisory Board. Dr. Ohrui is a distinguished ...

As previously communicated, the planned Phase IIa study will be conducted in two parts. Part 1 aims to establish dosage levels and safety of sevuparin through single doses in 25-30 patients with ...

THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at ...

PHIOGEN, a biotech company developing live biotherapeutic products (LBPs) for drug-resistant and recurrent bacterial infections, is collaborating with patient research and advocacy organization Live ...

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates Foundation ...